
Pembrolizumab combined with FOLFOX4 chemotherapy for treatment of advanced hepatocellular carcinoma: Clinical efficacy and impact on serum levels of VEGF, TGF-β1, and bFGF
Author(s) -
Zhaohui Zheng,
Xiao-Le He
Publication year - 2022
Publication title -
shijie huaren xiaohua zazhi
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.114
H-Index - 16
eISSN - 2219-2859
pISSN - 1009-3079
DOI - 10.11569/wcjd.v30.i11.504
Subject(s) - hepatocellular carcinoma , medicine , pembrolizumab , vegf receptors , oncology , chemotherapy , gastroenterology , cancer , immunotherapy